12 Jan DecisionRx Appoints Jamie Wilkey, PharmD, as Clinical Advisor
INDIANAPOLIS, January 12, 2024 – DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping physicians eliminate medication failure, today announced the appointment of Jamie Wilkey, PharmD, as Clinical Advisor to its Clinical Advisory Board. In this role, Dr. Wilkey will counsel DecisionRx’s senior leadership on communication, education, and implementation of pharmacogenomics among pharmacists, payers, prescribers, and patients.
“Having inspired and trained scores of precision-medicine pharmacists, Dr. Wilkey is uniquely positioned to help us recruit and retain our growing network of highly-trained talent. These pharmacists are necessary to deliver impactful medication therapy optimization interventions using the DecisionRx technology platform,” said DecisionRx CEO James Wallace. “As we continue scaling, patients nationwide will reap the benefits of medication therapy optimization with our platform as it is designed to mitigate drug failure, leading to healthier patients and less expensive care.”
Dr. Wilkey is based in Utah and received her Doctor of Pharmacy from the University of Wyoming School of Pharmacy. She’s an entrepreneur, having built a $1M+ precision medicine company in less two years and one of the top five most-followed PharmD’s on LinkedIn. In the last 10 years, she has worked with national pharmacies including Walgreens and Rite Aid. Additionally, Dr. Wilkey serves as an Adjunct Professor at the University of Florida and is an active member of Pharmacy Times’ Educational Advisory Board.
“I am eager to help DecisionRx continue to bring medication therapy optimization to more physicians and patients,” said Dr. Wilkey. “I am particularly interested in increasing awareness of the health advantages associated with this cutting-edge science. I’ve seen extremely positive outcomes from the DecisionRx platform, which has overwhelmingly improved their overall health and medication adherence.”
About DecisionRx
DecisionRx is a technology-enabled healthcare services company, improving patient outcomes and reducing healthcare costs by helping physicians optimize prescribing decisions for their patients. DecisionRx clinical pharmacists work on patients’ behalf to mitigate medication failure by making personalized medication recommendations to prescribers, informed by the latest clinical and data-science, and delivered in a value-based care model. Medication failure accounts for at least 16% of total healthcare spending, and medication therapy optimization has been shown to reduce total annualized cost of care by $3,600 for Medicare patients and $1,200 for patients under age 65.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Global Investment Solutions. With $382 billion of assets under management as of September 30, 2023, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies and the communities in which we live and invest. Carlyle employs more than 2,200 people in 28 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle.
Contacts
Media
Kyle Evans
ICR Westwicke on behalf of DecisionRx
646-677-1295
Kyle.Evans@westwicke.com